In this report, Meddevicetracker covers catalysts from 11 devices expected to occur in Q4 2018. These include important regulatory milestones and trial updates across the cardiovascular, neurology, diabetes, orthopedics, autoimmune/immunology, and oncology spaces. Additionally, at the end of this report we have included a list of Large Impact catalysts through Q4 2018.

For more information on Meddevicetracker, visit its website www.meddevicetracker.com.

Like our report? Have any questions or feedback? Please let us know at mdtaskanalyst@sagientresearch.com.